Title,Authors,Platform,Cited_url,Cited_count,Year
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis,"S Sawcer, G Hellenthal, M Pirinen, CCA Spencer, NA Patsopoulos, ...","Nature 476 (7359), 214",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7783309922267322453,1898,2011
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity,"R Roxburgh, SR Seaman, T Masterman, AE Hensiek, SJ Sawcer, ...","Neurology 64 (7), 1144-1151",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13018683591240852542,734,2005
Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis,"M Tintoré, A Rovira, MJ Martínez, J Rio, P Díaz-Villoslada, L Brieva, ...","American Journal of Neuroradiology 21 (4), 702-706",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3228846937192314971,568,2000
Heterogeneity at the ,"LF Barcellos, S Sawcer, PP Ramsay, SE Baranzini, G Thomson, F Briggs, ...","Human molecular genetics 15 (18), 2813-2824",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11813865297204328294,317,2006
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS,"J Sepulcre, M Murie-Fernandez, A Salinas-Alaman, A García-Layana, ...","Neurology 68 (18), 1488-1494",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12918323907802230501,307,2007
MRI characteristics of neuromyelitis optica spectrum disorder: an international update,"HJ Kim, F Paul, MA Lana-Peixoto, S Tenembaum, N Asgari, J Palace, ...","Neurology 84 (11), 1165-1173",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13855283073083829530,292,2015
Analysis and application of European genetic substructure using 300 K SNP information,"C Tian, RM Plenge, M Ransom, A Lee, P Villoslada, C Selmi, L Klareskog, ...","PLoS genetics 4 (1), e4",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17835545081517344710,267,2008
European population substructure: clustering of northern and southern populations,"MF Seldin, R Shigeta, P Villoslada, C Selmi, J Tuomilehto, G Silva, ...","PLoS genetics 2 (9), e143",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13803533944908582594,252,2006
Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central …,"P Villoslada, SL Hauser, I Bartke, J Unger, N Heald, D Rosenberg, ...","Journal of Experimental Medicine 191 (10), 1799-1806",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=386259604986605571,250,2000
Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test,"J Sepulcre, S Vanotti, R Hernández, G Sandoval, F Cáceres, O Garcea, ...","Multiple Sclerosis Journal 12 (2), 187-195",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17936567764223858261,201,2006
Transcription-based prediction of response to IFNβ using supervised computational methods,"SE Baranzini, P Mousavi, J Rio, SJ Caillier, A Stillman, P Villoslada, ...","PLoS biology 3 (1), e2",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10782346032191941706,200,2004
Analysis of relapses in anti-NMDAR encephalitis,"I Gabilondo, A Saiz, L Galan, V González, R Jadraque, L Sabater, A Sans, ...","Neurology 77 (10), 996-999",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13759597400510148675,194,2011
Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study,"J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ...","Multiple Sclerosis Journal 21 (8), 1013-1024",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15328485545921541695,181,2015
Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis,"E Byun, SJ Caillier, X Montalban, P Villoslada, O Fernández, D Brassat, ...","Archives of neurology 65 (3), 337-344",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3906806784500950574,177,2008
Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis,"PH Lalive, T Menge, C Delarasse, B Della Gaspera, D Pham-Dinh, ...","Proceedings of the National Academy of Sciences 103 (7), 2280-2285",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17458149470220294235,175,2006
Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways,"J Sepulcre, JC Masdeu, J Goni, G Arrondo, N Velez de Mendizabal, ...","Multiple Sclerosis Journal 15 (3), 337-344",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12425567225315288836,161,2009
Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis,"J Toledo, J Sepulcre, A Salinas-Alaman, A Garcia-Layana, ...","Multiple Sclerosis Journal 14 (7), 906-912",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=78564568492213435,159,2008
Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation,"A Di Penta, B Moreno, S Reix, B Fernandez-Diez, M Villanueva, O Errea, ...","PLoS one 8 (2), e54722",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8786521900387458226,158,2013
Trans‐synaptic axonal degeneration in the visual pathway in multiple sclerosis,"I Gabilondo, EH Martínez‐Lapiscina, E Martínez‐Heras, E Fraga‐Pumar, ...","Annals of neurology 75 (1), 98-107",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15536574773738127638,157,2014
The investigation of acute optic neuritis: a review and proposed protocol,"A Petzold, MP Wattjes, F Costello, J Flores-Rivera, CL Fraser, K Fujihara, ...","Nature Reviews Neurology 10 (8), 447-458",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14910588380404700973,156,2014
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study,"EH Martinez-Lapiscina, S Arnow, JA Wilson, S Saidha, JL Preiningerova, ...","The Lancet Neurology 15 (6), 574-584",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16778666765214086224,152,2016
Neuromyelitis optica and multiple sclerosis: seeing differences through optical coherence tomography,"JL Bennett, J De Seze, M Lana-Peixoto, J Palace, A Waldman, ...","Multiple Sclerosis Journal 21 (6), 678-688",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17356352310114779905,140,2015
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease,"H Perron, R Germi, C Bernard, M Garcia-Montojo, C Deluen, L Farinelli, ...","Multiple Sclerosis Journal 18 (12), 1721-1736",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17916047527064654299,138,2012
Making sense of big data in health research: towards an EU action plan,"C Auffray, R Balling, I Barroso, L Bencze, M Benson, J Bergeron, ...","Genome medicine 8 (1), 71",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=640863766463305221,137,2016
IL‐10 suppressor activity and ,"I Martinez‐Forero, R Garcia‐Munoz, S Martinez‐Pasamar, S Inoges, ...","European journal of immunology 38 (2), 576-586",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5547563332289142673,135,2008
Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination,"HC Von Bũdingen, N Tanuma, P Villoslada, JC Ouallet, SL Hauser, ...","Journal of clinical immunology 21 (3), 155-170",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15303689206110215185,132,2001
"Modules, networks and systems medicine for understanding disease and aiding diagnosis","M Gustafsson, CE Nestor, H Zhang, AL Barabási, S Baranzini, S Brunak, ...","Genome medicine 6 (10), 82",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10040890965128705592,124,2014
The APOSTEL recommendations for reporting quantitative optical coherence tomography studies,"A Cruz-Herranz, LJ Balk, T Oberwahrenbrock, S Saidha, ...","Neurology 86 (24), 2303-2309",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3751613191888078882,121,2016
Role of nerve growth factor and other trophic factors in brain inflammation,"P Villoslada, CP Genain","Progress in brain research 146, 403-414",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10643604369928038271,120,2004
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis,"A Petzold, LJ Balcer, PA Calabresi, F Costello, TC Frohman, EM Frohman, ...","The Lancet Neurology 16 (10), 797-812",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2798852222074755010,116,2017
Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria,"S Schippling, LJ Balk, F Costello, P Albrecht, L Balcer, PA Calabresi, ...","Multiple sclerosis journal 21 (2), 163-170",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5495085252532983084,108,2015
Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis,"S Llufriu, M Sepúlveda, Y Blanco, P Marín, B Moreno, J Berenguer, ...","PloS one 9 (12), e113936",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15064637742781225419,107,2014
Systems biology and its application to the understanding of neurological diseases,"P Villoslada, L Steinman, SE Baranzini",Annals of Neurology: Official Journal of the American Neurological …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7231933555822463704,107,2009
Memantine induces reversible neurologic impairment in patients with MS,"P Villoslada, G Arrondo, J Sepulcre, M Alegre, J Artieda","Neurology 72 (19), 1630-1633",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12467659919086533091,100,2009
Systemic inflammation induces axon injury during brain inflammation,"B Moreno, JP Jukes, N Vergara‐Irigaray, O Errea, P Villoslada, VH Perry, ...","Annals of neurology 70 (6), 932-942",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4579533095846013975,99,2011
Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway,"J Sepulcre, J Goñi, JC Masdeu, B Bejarano, NV de Mendizábal, ...","Archives of neurology 66 (2), 173-179",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17585283913971716447,95,2009
A computational analysis of protein-protein interaction networks in neurodegenerative diseases,"J Goñi, FJ Esteban, NV de Mendizábal, J Sepulcre, S Ardanza-Trevijano, ...","BMC systems biology 2 (1), 52",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=306271041799812942,94,2008
European population genetic substructure: further definition of ancestry informative markers for distinguishing among diverse European ethnic groups,"C Tian, R Kosoy, R Nassir, A Lee, P Villoslada, L Klareskog, ...","Molecular Medicine 15 (11-12), 371-383",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11236472927096748297,86,2009
Dynamics of retinal injury after acute optic neuritis,"I Gabilondo, EH Martínez‐Lapiscina, E Fraga‐Pumar, S Ortiz‐Perez, ...","Annals of neurology 77 (3), 517-528",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2815511004473236829,84,2015
Fractal dimension and white matter changes in multiple sclerosis,"FJ Esteban, J Sepulcre, NV de Mendizábal, J Goñi, J Navas, JR de Miras, ...","Neuroimage 36 (3), 543-549",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6277186989655469209,84,2007
"The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-β","P Villoslada, LF Barcellos, J Rio, AB Begovich, M Tintore, ...","Journal of neuroimmunology 130 (1-2), 194-201",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5124450655620561423,83,2002
Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen,"P Diaz-Villoslada, A Shih, L Shao, CP Genain, SL Hauser","Journal of neuroimmunology 99 (1), 36-43",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15960287143136714738,82,1999
Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis,"U Sriram, LF Barcellos, P Villoslada, J Rio, SE Baranzini, S Caillier, ...","Genes and immunity 4 (2), 147",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9180578013186917376,80,2003
Increased expression of cystine/glutamate antiporter in multiple sclerosis,"O Pampliega, M Domercq, FN Soria, P Villoslada, ...","Journal of neuroinflammation 8 (1), 63",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=863868236032441362,78,2011
The semantic organization of the animal category: evidence from semantic verbal fluency and network theory,"J Goñi, G Arrondo, J Sepulcre, I Martincorena, NV de Mendizábal, ...","Cognitive processing 12 (2), 183-196",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13747049787584337670,74,2011
Neuromyelitis optica spectrum disorders: comparison according to the phenotype and serostatus,"M Sepúlveda, T Armangué, N Sola-Valls, G Arrambide, JE Meca-Lallana, ...","Neurology-Neuroimmunology Neuroinflammation 3 (3), e225",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15456106927158954798,72,2016
Color vision is strongly associated with retinal thinning in multiple sclerosis,"P Villoslada, A Cuneo, J Gelfand, SL Hauser, A Green","Multiple Sclerosis Journal 18 (7), 991-999",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5064420597538784114,72,2012
Analysis of the ,"A García‐Redondo, O Dols‐Icardo, R Rojas‐García, J Esteban‐Pérez, ...","Human mutation 34 (1), 79-82",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=916083160687742233,70,2013
Fractal-dimension analysis detects cerebral changes in preterm infants with and without intrauterine growth restriction,"FJ Esteban, N Padilla, M Sanz-Cortés, JR de Miras, N Bargalló, ...","Neuroimage 53 (4), 1225-1232",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13496995311672324611,68,2010
Fractal dimension analysis of grey matter in multiple sclerosis,"FJ Esteban, J Sepulcre, JR de Miras, J Navas, NV de Mendizábal, J Goñi, ...","Journal of the neurological sciences 282 (1-2), 67-71",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5666289359848496019,68,2009
Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study,"S Llufriu, Y Blanco, E Martinez-Heras, J Casanova-Molla, I Gabilondo, ...","PloS one 7 (5), e37167",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8495289002346373494,66,2012
Memory decline evolves independently of disease activity in MS,"B Duque, J Sepulcre, B Bejarano, L Samaranch, P Pastor, P Villoslada","Multiple Sclerosis Journal 14 (7), 947-953",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9696833602518325135,65,2008
The proteasome is a major autoantigen in multiple sclerosis,"I Mayo, J Arribas, P Villoslada, R Alvarez DoForno, S Rodríguez‐Vilariño, ...","Brain 125 (12), 2658-2667",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9957689113393921119,65,2002
"Frequency, heterogeneity and encephalitogenicity of T cells specific for myelin oligodendrocyte glycoprotein in naive outbred primates","P Villoslada, K Abel, N Heald, R Goertsches, SL Hauser, CP Genain","European journal of immunology 31 (10), 2942-2950",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1727795766563046420,65,2001
Acute optic neuritis: unmet clinical needs and model for new therapies,"SL Galetta, P Villoslada, N Levin, K Shindler, H Ishikawa, E Parr, ...","Neurology-Neuroimmunology Neuroinflammation 2 (4), e135",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10361039509317100144,64,2015
Methylthioadenosine reverses brain autoimmune disease,"B Moreno, H Hevia, M Santamaria, J Sepulcre, J Munoz, ...",Annals of Neurology: Official Journal of the American Neurological …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3583650888628688158,61,2006
Mapping the brain pathways of declarative verbal memory: Evidence from white matter lesions in the living human brain,"J Sepulcre, JC Masdeu, J Sastre-Garriga, J Goñi, N Vélez-de-Mendizábal, ...","Neuroimage 42 (3), 1237-1243",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1487113148430991142,58,2008
Gain-of-function of P2X7 receptor gene variants in multiple sclerosis,"O Oyanguren-Desez, A Rodríguez-Antigüedad, P Villoslada, M Domercq, ...","Cell calcium 50 (5), 468-472",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4412271004549243586,57,2011
Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis,"O Pampliega, M Domercq, P Villoslada, J Sepulcre, ...","Journal of neuroimmunology 195 (1-2), 194-198",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10581407390895667900,57,2008
A network analysis of the human T-cell activation gene network identifies JAGGED1 as a therapeutic target for autoimmune diseases,"R Palacios, J Goni, I Martinez-Forero, J Iranzo, J Sepulcre, I Melero, ...","PLoS One 2 (11), e1222",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12773990209313202306,56,2007
Allele-specific gene expression is widespread across the genome and biological processes,"R Palacios, E Gazave, J Goñi, G Piedrafita, O Fernando, A Navarro, ...","PLoS One 4 (1), e4150",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12615449923717295786,53,2009
The immune response against herpesvirus is more prominent in the early stages of MS,"P Villoslada, C Juste, M Tintore, V Llorenc, G Codina, P Pozo-Rosich, ...","Neurology 60 (12), 1944-1948",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6782090124889923822,52,2003
Genome-wide analysis of wild-type Epstein–Barr virus genomes derived from healthy individuals of the 1000 Genomes Project,"G Santpere, F Darre, S Blanco, A Alcami, P Villoslada, M Mar Alba, ...","Genome biology and evolution 6 (4), 846-860",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7712590103264302705,50,2014
A genomic screen of Spanish multiple sclerosis patients reveals multiple loci associated with the disease,"R Goertsches, P Villoslada, M Comabella, X Montalban, A Navarro, ...","Journal of neuroimmunology 143 (1-2), 124-128",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15912885645270154810,50,2003
"Frequency of multiple sclerosis in Menorca, Balearic islands, Spain","P Casquero, P Villoslada, X Montalbán, M Torrent","Neuroepidemiology 20 (2), 129-133",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16595626054693981810,50,2001
Lesions in the posterior visual pathway promote trans-synaptic degeneration of retinal ganglion cells,"J Keller, BF Sánchez-Dalmau, P Villoslada","PLoS One 9 (5), e97444",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5562280300087343915,45,2014
Response to immunotherapy in CLIPPERS syndrome,"I Gabilondo, A Saiz, F Graus, P Villoslada","Journal of neurology 258 (11), 2090-2092",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2441560782409419571,45,2011
Immunotherapy for neurological diseases,"P Villoslada, B Moreno, I Melero, JL Pablos, G Martino, A Uccelli, ...","Clinical immunology 128 (3), 294-305",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13323753615036573539,45,2008
Reversible white matter alterations in encephalopathy associated with autoimmune thyroid disease,"P Pozo-Rosich, P Villoslada, A Canton, R Simo, A Rovira, X Montalban","Journal of neurology 249 (8), 1063-1065",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17132113593999274894,45,2002
Computational disease modeling–fact or fiction?,"JN Tegnér, A Compte, C Auffray, G An, G Cedersund, G Clermont, ...","BMC systems biology 3 (1), 56",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10334076405529201373,42,2009
Targeting NGF-pathway for developing neuroprotective therapies for multiple sclerosis and other neurological diseases,"V Colafrancesco, P Villoslada","Archives italiennes de biologie 149 (2), 183-192",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9182242922004556495,41,2011
Brain pathways of verbal working memory: a lesion–function correlation study,"J Sepulcre, JC Masdeu, MA Pastor, J Goñi, C Barbosa, B Bejarano, ...","Neuroimage 47 (2), 773-778",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17313629630406921770,41,2009
Colour vision impairment is associated with disease severity in multiple sclerosis,"EH Martínez-Lapiscina, S Ortiz-Pérez, E Fraga-Pumar, E Martínez-Heras, ...","Multiple Sclerosis Journal 20 (9), 1207-1216",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1122945803999459258,40,2014
Cognitive functions in multiple sclerosis: impact of gray matter integrity,"S Llufriu, E Martinez-Heras, J Fortea, Y Blanco, J Berenguer, I Gabilondo, ...","Multiple Sclerosis Journal 20 (4), 424-432",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14083659231511105579,40,2014
Multiple sclerosis susceptibility genes: associations with relapse severity and recovery,"EM Mowry, RF Carey, MR Blasco, J Pelletier, P Duquette, P Villoslada, ...","PloS one 8 (10), e75416",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4100338480102573933,39,2013
TNF-376A marks susceptibility to MS in the Spanish population: A replication study,"A Martinez, A Rubio, E Urcelay, M Fernández-Arquero, V De Las Heras, ...","Neurology 62 (5), 809-810",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8889223643637800003,39,2004
Use of advanced magnetic resonance imaging techniques in neuromyelitis optica spectrum disorder,"S Kremer, F Renard, S Achard, MA Lana-Peixoto, J Palace, N Asgari, ...","JAMA neurology 72 (7), 815-822",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3380885580870720979,38,2015
Multiple sclerosis and HERV-W/MSRV: a multicentric study,"G Arru, G Mameli, V Astone, C Serra, YM Huang, H Link, E Fainardi, ...","International journal of biomedical science: IJBS 3 (4), 292",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13732648396596303585,38,2007
Analysis of prognostic factors associated with longitudinally extensive transverse myelitis,"M Sepúlveda, Y Blanco, A Rovira, J Rio, M Mendibe, S Llufriu, ...","Multiple Sclerosis Journal 19 (6), 742-748",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16168632980399435417,37,2013
Genomic regulation of CTLA4 and multiple sclerosis,"R Palacios, D Comas, J Elorza, P Villoslada","Journal of neuroimmunology 203 (1), 108-115",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12720013969984203373,37,2008
Data integration and systems biology approaches for biomarker discovery: challenges and opportunities for multiple sclerosis,"P Villoslada, S Baranzini","Journal of neuroimmunology 248 (1-2), 58-65",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6115518555459535749,35,2012
Clinical characteristics of responders to interferon therapy for relapsing MS,"P Villoslada, JR Oksenberg, J Rio, X Montalban","Neurology 62 (9), 1653-1653",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10270564109395229581,35,2004
Structural networks involved in attention and executive functions in multiple sclerosis,"S Llufriu, E Martinez-Heras, E Solana, N Sola-Valls, M Sepulveda, ...","NeuroImage: Clinical 13, 288-296",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8425515948189939854,33,2017
The disruption of mitochondrial axonal transport is an early event in neuroinflammation,"O Errea, B Moreno, A Gonzalez-Franquesa, PM Garcia-Roves, ...","Journal of neuroinflammation 12 (1), 152",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2222241841622666006,33,2015
The visual pathway as a model to understand brain damage in multiple sclerosis,"EH Martínez-Lapiscina, B Sanchez-Dalmau, E Fraga-Pumar, ...","Multiple Sclerosis Journal 20 (13), 1678-1685",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13003535834464919836,32,2014
Modeling the effector-regulatory T cell cross-regulation reveals the intrinsic character of relapses in Multiple Sclerosis,"NV de Mendizábal, J Carneiro, RV Solé, J Goñi, J Bragard, ...","BMC Systems Biology 5 (1), 114",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9294303686693091817,32,2011
Abnormalities in brain synchronization are correlated with cognitive impairment in multiple sclerosis,"G Arrondo, M Alegre, J Sepulcre, J Iriarte, J Artieda, P Villoslada","Multiple Sclerosis Journal 15 (4), 509-516",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13165219761094001395,32,2009
A Web platform for the interactive visualization and analysis of the 3D fractal dimension of MRI data,"J Jiménez, AM López, J Cruz, FJ Esteban, J Navas, P Villoslada, ...","Journal of biomedical informatics 51, 176-190",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2158397732653820180,31,2014
Computational classifiers for predicting the short-term course of Multiple sclerosis,"B Bejarano, M Bianco, D Gonzalez-Moron, J Sepulcre, J Goñi, J Arcocha, ...","BMC neurology 11 (1), 67",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6730372404970071451,31,2011
Pharmacogenomics of Type I interferon therapy: a survey of response-modifying genes,"C O’Doherty, P Villoslada, K Vandenbroeck","Cytokine & growth factor reviews 18 (3-4), 211-222",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17510878522829272526,30,2007
Jun expression is found in neurons located in the vicinity of subacute plaques in patients with multiple sclerosis,"G Martin, J Segui, P Diaz-Villoslada, X Montalban, AM Planas, I Ferrer","Neuroscience letters 212 (2), 95-98",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5059782189124093161,30,1996
Challenges and opportunities in designing clinical trials for neuromyelitis optica,"BG Weinshenker, G Barron, JM Behne, JL Bennett, PS Chin, BAC Cree, ...","Neurology 84 (17), 1805-1815",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4448695781027867938,28,2015
Triiodothyronine administration ameliorates the demyelination/remyelination ratio in a non‐human primate model of multiple sclerosis by correcting tissue hypothyroidism,"G D’Intino, L Lorenzini, M Fernandez, A Taglioni, G Perretta, ...","Journal of neuroendocrinology 23 (9), 778-790",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1833777488719032208,27,2011
Biomarkers for multiple sclerosis,P Villoslada,"Drug News Perspect 23 (9), 585-95",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=267352394370886852,27,2010
Pharmacogenomics of multiple sclerosis: in search for a personalized therapy,"I Martinez-Forero, A Pelaez, P Villoslada","Expert opinion on pharmacotherapy 9 (17), 3053-3067",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8339771723364033333,27,2008
Color vision impairment in multiple sclerosis points to retinal ganglion cell damage,"EJ Lampert, M Andorra, R Torres-Torres, S Ortiz-Pérez, S Llufriu, ...","Journal of neurology 262 (11), 2491-2497",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11993624653051418370,26,2015
Mitochondrial haplogroups in Basque multiple sclerosis patients,"D Otaegui, A Saenz, M Martinez-Zabaleta, P Villoslada, ...","Multiple Sclerosis Journal 10 (5), 532-535",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6201342956502584991,26,2004
Retinal periphlebitis is associated with multiple sclerosis severity,"S Ortiz-Pérez, EH Martínez-Lapiscina, I Gabilondo, E Fraga-Pumar, ...","Neurology 81 (10), 877-881",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6304795320269381473,25,2013
Multicenter reliability of semiautomatic retinal layer segmentation using OCT,"T Oberwahrenbrock, GL Traber, S Lukas, I Gabilondo, R Nolan, ...","Neurology-Neuroimmunology Neuroinflammation 5 (3), e449",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12123120489088655028,24,2018
Power estimation for non-standardized multisite studies,"A Keshavan, F Paul, MK Beyer, AH Zhu, N Papinutto, RT Shinohara, ...","NeuroImage 134, 281-294",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10099292263234111362,24,2016
Preclinical studies of methylthioadenosine for the treatment of multiple sclerosis,"B Moreno, B Fernandez-Diez, A Di Penta, P Villoslada","Multiple Sclerosis Journal 16 (9), 1102-1108",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7760997533062397325,24,2010
A preliminary study of the frequency of anti-basal ganglia antibodies and streptococcal infection in attention deficit/hyperactivity disorder,"R Sanchez-Carpintero, SA Albesa, N Crespo, P Villoslada, J Narbona","Journal of neurology 256 (7), 1103-1108",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18342756332940185038,24,2009
Neuroprotective therapies for multiple sclerosis and other demyelinating diseases,P Villoslada,"Multiple Sclerosis and Demyelinating Disorders 1 (1), 1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10509777702106144743,21,2016
HLA-DRB1 typing in Caucasians patients with neuromyelitis optica,"Y Blanco, G Ercilla-Gonzalez, S Llufriu, B Casanova-Estruch, ...","Revista de neurologia 53 (3), 146-152",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9449304805631407179,21,2011
Narrative speech is impaired in multiple sclerosis,"G Arrondo, J Sepulcre, B Duque, J Toledo, P Villoslada","The European Neurological Journal 2 (1), 1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12269434449942708649,21,2010
Metabolomic signatures associated with disease severity in multiple sclerosis,"P Villoslada, C Alonso, I Agirrezabal, E Kotelnikova, I Zubizarreta, ...","Neurology-Neuroimmunology Neuroinflammation 4 (2), e321",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4976862261725601282,20,2017
The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS,"EH Martínez-Lapiscina, E Fraga-Pumar, I Gabilondo, E Martínez-Heras, ...","BMC research notes 7 (1), 910",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17080360599561340932,20,2014
"Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008–2012","EH Martinez-Lapiscina, E Fraga-Pumar, X Pastor, M Gomez, A Conesa, ...","Journal of neurology 261 (4), 759-767",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1991007040572074606,20,2014
Steady state detection of chemical reaction networks using a simplified analytical method,"I Martínez-Forero, A Peláez-López, P Villoslada","PloS one 5 (6), e10823",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4466117472387266542,20,2010
Antibodies against Epstein–Barr virus and herpesvirus type 6 are associated with the early phases of Multiple Sclerosis,"M Riverol, J Sepulcre, M Fernandez-Alonso, A Uccelli, L Brieva, M Rubio, ...","Journal of neuroimmunology 192 (1), 184-185",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4865172442933892916,20,2007
First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases,"A Borroto, D Reyes-Garau, MA Jiménez, E Carrasco, B Moreno, ...","Science translational medicine 8 (370), 370ra184-370ra184",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11502781431821848966,19,2016
Knowledge retrieval from PubMed abstracts and electronic medical records with the Multiple Sclerosis Ontology,"A Malhotra, M Gündel, AM Rajput, HT Mevissen, A Saiz, X Pastor, ...","PloS one 10 (2), e0116718",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2521156612553414061,19,2015
Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity,"S Martinez-Pasamar, E Abad, B Moreno, NV de Mendizabal, ...","BMC systems biology 7 (1), 34",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13347083666702609828,19,2013
Switcher-random-walks: A cognitive-inspired mechanism for network exploration,"J Goñi, I Martincorena, B Corominas-Murtra, G Arrondo, ...","International Journal of Bifurcation and Chaos 20 (03), 913-922",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16675565588700568733,19,2010
Analysis of antibodies to surface epitopes of contactin-2 in multiple sclerosis,"A Boronat, M Sepúlveda, S Llufriu, L Sabater, Y Blanco, I Gabilondo, ...","Journal of neuroimmunology 244 (1-2), 103-106",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10568099416821580442,18,2012
Restoring immune tolerance in neuromyelitis optica: Part I,"L Steinman, A Bar-Or, JM Behne, D Benitez-Ribas, PS Chin, ...","Neurology-Neuroimmunology Neuroinflammation 3 (5), e276",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7997798030065731859,17,2016
Improved framework for tractography reconstruction of the optic radiation,"E Martinez-Heras, F Varriano, V Prčkovska, C Laredo, M Andorra, ...","PLoS One 10 (9), e0137064",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6504753081507044374,17,2015
Association of multiple sclerosis susceptibility variants and early attack location in the CNS,"EM Mowry, RF Carey, MR Blasco, J Pelletier, P Duquette, P Villoslada, ...","PloS one 8 (10), e75565",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9962588532319340364,16,2013
Lexical access changes in patients with multiple sclerosis: A two-year follow-up study,"J Sepulcre, H Peraita, J Goñi, G Arrondo, I Martincorena, B Duque, ...","Journal of clinical and experimental neuropsychology 33 (2), 169-175",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1425918402717612480,16,2011
Early retinal atrophy predicts long-term visual impairment after acute optic neuritis,"B Sanchez-Dalmau, EH Martinez-Lapiscina, R Torres-Torres, ...","Multiple Sclerosis Journal 24 (9), 1196-1204",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7517095094955735853,15,2018
Restoring immune tolerance in neuromyelitis optica: Part II,"A Bar-Or, L Steinman, JM Behne, D Benitez-Ribas, PS Chin, ...","Neurology-Neuroimmunology Neuroinflammation 3 (5), e277",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1933414769075288188,15,2016
Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders,"EH Martinez-Lapiscina, M Sepulveda, R Torres-Torres, S Alba-Arbalat, ...","Therapeutic advances in neurological disorders 9 (5), 436-440",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16910448129201915383,15,2016
Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: a pilot study,"M Sepúlveda, C Ros, EH Martínez-Lapiscina, N Solà-Valls, M Hervàs, ...","Multiple Sclerosis Journal 22 (4), 564-568",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3860848591183602444,15,2016
Signaling networks in MS: a systems-based approach to developing new pharmacological therapies,"E Kotelnikova, M Bernardo-Faura, G Silberberg, NA Kiani, D Messinis, ...","Multiple Sclerosis Journal 21 (2), 138-146",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4866132571968202874,15,2015
Dynamic molecular monitoring of retina inflammation by ,"M Marro, A Taubes, A Abernathy, S Balint, B Moreno, B Sanchez‐Dalmau, ...","Journal of biophotonics 7 (9), 724-734",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4843719170727446774,15,2014
UJA-3DFD: A program to compute the 3D fractal dimension from MRI data,"JR de Miras, J Navas, P Villoslada, FJ Esteban","Computer methods and programs in biomedicine 104 (3), 452-460",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=397436155554714383,15,2011
Neuroinformatics in clinical practice: are computers going to help neurological patients and their physicians?,"P Villoslada, JR Oksenberg","Future Medicine Ltd 1 (2), 159-170",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16456631310334164458,15,2006
Changes in macular layers in the early course of non-arteritic ischaemic optic neuropathy,"J Keller, JD Oakley, DB Russakoff, M Andorrà-Inglés, P Villoslada, ...","Graefe's Archive for Clinical and Experimental Ophthalmology 254 (3), 561-567",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11072608309643354581,14,2016
Transient oscillatory dynamics of interferon beta signaling in macrophages,"I Pertsovskaya, E Abad, N Domedel-Puig, J Garcia-Ojalvo, P Villoslada","BMC systems biology 7 (1), 59",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13860169685746376768,14,2013
Retrograde retinal damage after acute optic tract lesion in MS,"I Gabilondo, M Sepúlveda, S Ortiz-Perez, E Fraga-Pumar, ...","J Neurol Neurosurg Psychiatry 84 (7), 824-826",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11863123653897526620,14,2013
Differential neuroprotective effects of 5′-deoxy-5′-methylthioadenosine,"B Moreno, I Lopez, B Fernández-Díez, M Gottlieb, C Matute, ...","PloS one 9 (3), e90671",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14054243850101803953,13,2014
Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach,"NV de Mendizabal, MM Hutmacher, IF Troconiz, J Goñi, P Villoslada, ...","PLoS One 8 (9), e73361",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=986036169606429978,13,2013
Guidelines on the appropriate use of animal models for developing therapies in multiple sclerosis,"B Moreno, C Espejo, L Mestre, M Suardiaz, D Clemente, ...","Revista de neurologia 54 (2), 114-124",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11483546387947065904,13,2012
Tolerogenic dendritic cells as a promising antigen-specific therapy in the treatment of multiple sclerosis and neuromyelitis optica from preclinical to clinical trials,"G Flórez-Grau, I Zubizarreta, R Cabezón, P Villoslada, D Benitez-Ribas","Frontiers in immunology 9, 1169",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5685091582129952579,12,2018
Visual field impairment captures disease burden in multiple sclerosis,"S Ortiz-Perez, M Andorra, B Sanchez-Dalmau, R Torres–Torres, D Calbet, ...","Journal of neurology 263 (4), 695-702",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10676550094387576254,12,2016
Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study,"RC Nolan‐Kenney, M Liu, O Akhand, PA Calabresi, F Paul, A Petzold, ...","Annals of neurology 85 (5), 618-629",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7413841910977514377,11,2019
A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation,"A Di Penta, A Chiba, I Alloza, A Wyssenbach, T Yamamura, P Villoslada, ...","PLoS One 8 (12), e83119",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4995360870033642373,11,2013
T2 hypointense rims and ring-enhancing lesions in MS,"S Llufriu, T Pujol, Y Blanco, K Hankiewicz, M Squarcia, J Berenguer, ...","Multiple Sclerosis Journal 16 (11), 1317-1325",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17191011819493985140,11,2010
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis,"P Villoslada, J Sepulcre, J Toledo, B Bejarano","Neurology 71 (21), 1747-1748",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8342560076033845902,11,2008
Genetic analysis of SLC11A1 polymorphisms in multiple sclerosis patients,"M Comabella, L Altet, F Peris, P Villoslada, A Sánchez, X Montalban","Multiple Sclerosis Journal 10 (6), 618-620",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=978708116825905609,11,2004
Dynamics and heterogeneity of brain damage in multiple sclerosis,"E Kotelnikova, NA Kiani, E Abad, EH Martinez-Lapiscina, M Andorra, ...","PLoS computational biology 13 (10), e1005757",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9242574313720753490,10,2017
Walking function in clinical monitoring of multiple sclerosis by telemedicine,"N Sola-Valls, Y Blanco, M Sepúlveda, S Llufriu, EH Martínez-Lapiscina, ...","Journal of neurology 262 (7), 1706-1713",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17597885729292980833,10,2015
Retrograde trans-synaptic degeneration in MS: a missing link?,"RA Bermel, P Villoslada","Neurology 82 (24), 2152-2153",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13309976953499812228,10,2014
Evaluating structural connectomics in relation to different Q-space sampling techniques,"P Rodrigues, A Prats-Galino, D Gallardo-Pujol, P Villoslada, C Falcon, ...",International Conference on Medical Image Computing and Computer-Assisted …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15597130278087290902,10,2013
United Europeans for development of pharmacogenomics in multiple sclerosis network,"K Vandenbroeck, M Comabella, E Tolosa, R Goertsches, D Brassat, ...","Future Medicine Ltd 10 (5), 885-894",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17049320236190014336,10,2009
Treatment of autoimmune diseases: A systems biology approach,"IM Forero, AS Ibarrola, PV Díaz","Drug Discovery Today: Therapeutic Strategies 4 (1), 57-62",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5619313475888478580,10,2007
Assessing biological and methodological aspects of brain volume loss in multiple sclerosis,"M Andorra, K Nakamura, EJ Lampert, I Pulido-Valdeolivas, I Zubizarreta, ...","JAMA neurology 75 (10), 1246-1255",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9999527235091915875,9,2018
Contextual diffusion image post-processing aids clinical applications,"V Prčkovska, M Andorrà, P Villoslada, E Martinez-Heras, R Duits, D Fortin, ...",Visualization and Processing of Higher Order Descriptors for Multi-Valued …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7452014830590824447,9,2015
Esclerosis múltiple,P Villoslada,Marge Books,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3875073547586135092,9,2010
Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial,"I Zubizarreta, G Flórez-Grau, G Vila, R Cabezón, C España, M Andorra, ...","Proceedings of the National Academy of Sciences 116 (17), 8463-8470",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18399779590763688859,8,2019
Impairment of decision-making in multiple sclerosis: A neuroeconomic approach,"M Sepúlveda, B Fernández-Diez, EH Martínez-Lapiscina, S Llufriu, ...","Multiple Sclerosis Journal 23 (13), 1762-1771",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4102635975154583813,8,2017
Autoimmunity and tumor immunology: two facets of a probabilistic immune system,"J Iranzo, P Villoslada","BMC systems biology 8 (1), 120",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9928544620490939754,8,2014
Gangliosides do not elicit experimental autoimmune encephalomyelitis in Lewis rats and SJL mice,"I Sáez-Torres, P Dı́az-Villoslada, E Martı́nez-Cáceres, I Ferrer, ...","Journal of neuroimmunology 84 (1), 24-29",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5285877150611909182,8,1998
"Viva Europa, a land of excellence in research and innovation for health and wellbeing","C Auffray, M Sagner, S Abdelhak, I Adcock, A Agusti, M Amaral, ...","Progress in Preventive Medicine 2 (3), e006",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=638870102101140410,7,2017
HLA‐DR2 and White Matter Lesion Distribution in MS,"J Sepulcre, JC Masdeu, R Palacios, J Goñi, B Moreno, M Tainta, ...","Journal of Neuroimaging 18 (3), 328-331",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14823638888589543539,7,2008
Chronic inflammatory diseases of the nervous system,"P Diaz-Villoslada, JR Oksenberg","Current opinion in neurology 11 (3), 235-240",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16936718651576730008,7,1998
Reproducibility of the structural connectome reconstruction across diffusion methods,"V Prčkovska, P Rodrigues, A Puigdellivol Sanchez, M Ramos, M Andorra, ...","Journal of Neuroimaging 26 (1), 46-57",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7127959918563721141,6,2016
Multicenter inter-rater reliability of retinal layer segmentation using spectral-domain OCT,"T Oberwahrenbrock, G Traber, I Gabilondo, R Nolan, C Songster, L Balk, ...",ECTRIMS Meeting,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8383779000958496331,6,2013
Recommendations for the clinical use of motor evoked potentials in multiple sclerosis,"V Fernández, J Valls-Sole, JL Relova, N Raguer, F Miralles, L Dinca, ...","Neurología (English Edition) 28 (7), 408-416",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14043415921771398128,6,2013
Syphilitic meningoradiculitis in a patient with HIV,"P Díaz-Villoslada, M Lozano, C Nos, M Comabella, J Montalbán, ...","Neurologia (Barcelona, Spain) 9 (6), 253-255",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6896722423741674267,6,1994
Predictors of vision impairment in multiple sclerosis,"B Sanchez-Dalmau, EH Martinez-Lapiscina, I Pulido-Valdeolivas, ...","PloS one 13 (4), e0195856",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11283225862169363281,5,2018
"Increased expression of dedicator-cytokinesis-10, caspase-2 and Synaptotagmin-like 2 is associated with clinical disease activity in multiple sclerosis","I Agirrezabal, R Palacios, B Moreno, J Sepulcre, A Abernathy, A Saiz, ...","Multiple Sclerosis and Demyelinating Disorders 1 (1), 7",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15977432746900895595,5,2016
The analysis of semantic networks in multiple sclerosis identifies preferential damage of long-range connectivity,"E Abad, J Sepulcre, EH Martinez-Lapiscina, I Zubizarreta, J Garcia-Ojalvo, ...","Multiple sclerosis and related disorders 4 (5), 387-394",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8186700525153765933,5,2015
Recomendaciones para la utilización clínica del estudio de potenciales evocados motores en la esclerosis múltiple,"V Fernandez, J Valls-Sole, JL Relova, N Raguer, F Miralles, L Dinca, ...","Neurología 28 (7), 408-416",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4920994816966091120,5,2013
Fine specificities of T cell and B cell responses to myelin/oligodendrocyte glycoprotein in common marmosets,"CP Genain, N Belmar, P Diaz-Villoslada, SL Hauser","Journal of Neuroimmunology 90 (1), 34",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8563175046179389003,5,1998
Harnessing electronic medical records to advance research on multiple sclerosis,"V Damotte, A Lizée, M Tremblay, A Agrawal, P Khankhanian, ...","Multiple Sclerosis Journal 25 (3), 408-418",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15511820395026281259,4,2019
Long-term reduction of relapse rate and confirmed disability progression after 5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis,"SL Hauser, B Brochet, X Montalban, RT Naismith, JS Wolinsky, M Manfrini, ...","Mult Scler 24, 285-6",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16286011049922087099,4,2018
Annualized Relapse Rate and Confirmed Disability Progression in Patients Receiving Continuous Ocrelizumab or Switching From Interferon Beta-1a to Ocrelizumab Therapy in the …,"S Hauser, B Brochet, X Montalban, R Naismith, J Wolinsky, M Manfrini, ...","Neurology 90 (15 Supplement), P1. 366",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7780761586371982675,4,2018
Brain MRI Activity and Atrophy Measures in Patients Receiving Continuous Ocrelizumab or Switching From Interferon Beta-1a to Ocrelizumab Therapy in the Open-Label Extension …,"D Arnold, L Kappos, S Hauser, X Montalban, A Traboulsee, J Wolinsky, ...","Neurology 90 (15 Supplement), S6. 002",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7053451405353175183,4,2018
Precision medicine for multiple sclerosis: an update of the available biomarkers and their use in therapeutic decision making,"I Pulido-Valdeolivas, I Zubizarreta, EH Martinez-Lapiscina, P Villoslada","Expert Review of Precision Medicine and Drug Development 2 (6), 345-361",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4657019171412720504,4,2017
Phase 1b clinical trial with antigen-specific tolerogenic dendritic in Multiple Sclerosis and Neuromyelitis optica: safety and immunological effects (P2. 330),"IZ Nafarrate, G Florez, G Vila, R Cabezón, C España, D Benitez, S Varea, ...","Neurology 88 (16 Supplement), P2. 330",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8928898662861666645,4,2017
"Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial","P Villoslada, A Rovira, X Montalban, R Arroyo, F Paul, V Meca-Lallana, ...","Neurology-Neuroimmunology Neuroinflammation 2 (5), e147",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16964028820702732001,4,2015
Agonists of neurotrophin receptors and their use as medicaments,"P Villoslada, A Messeguer","US Patent 8,791,076",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5767016165771753713,4,2014
Peptoid Agonists of Nerve Growth Factor and Their Use as Medicaments,"B Moreno, P Villoslada, J Messeguer, G Navarro, A Messeguer","US Patent App. 13/393,458",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15262483715838908378,4,2012
Guía de uso adecuado de modelos animales para el desarrollo de terapias en esclerosis múltiple,"B Moreno, C Espejo, L Mestre, M Suardiaz, D Clemente, F de Castro, ...","Rev Neurol 54, 114-24",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14299327831898586507,4,2012
Neuroprotective therapies for multiple sclerosis,"B Moreno, P Villoslada","Euro Neurol Rev 7, 189-195",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3584002509606418299,4,2012
Chromosome 7q21–22 and multiple sclerosis,"P Villoslada, LF Barcellos, JR Oksenberg","Journal of neuroimmunology 150 (1), 1-2",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7356373895707774291,4,2004
Long-term reduction in brain MRI disease activity and atrophy after 5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis,"DL Arnold, L Kappos, SL Hauser, X Montalban, A Traboulsee, ...","Multiple sclerosis and related disorders 26, 265",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14863033069053344258,3,2018
Subgenual anterior cingulate cortex controls sadness-induced modulations of cognitive and emotional network hubs,"JP Ramirez-Mahaluf, J Perramon, B Otal, P Villoslada, A Compte","Scientific reports 8 (1), 8566",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=905154365539256743,3,2018
Time to Cognitive Worsening in Patients With Relapsing Multiple Sclerosis in Ocrelizumab Phase III Trials (S44. 005),"S Cohan, R Benedict, J De Seze, S Hauser, L Kappos, J Wolinsky, ...","Neurology 90 (15 Supplement), S44. 005",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1036873476559698305,3,2018
Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation,"B Moreno, G Vila, B Fernandez-Diez, R Vázquez, A di Penta, O Errea, ...","Multiple Sclerosis and Demyelinating Disorders 2 (1), 3",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17891516323482116096,3,2017
Data mining in multiple sclerosis: computational classifiers. Introduction and methods (Part I),"HB Bejarano, V Segura, P Villoslada","Revista Española de Esclerosis Múltiple 5, 5-15",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6514745033059243552,3,2013
Chromosome 5 and multiple sclerosis,"R Palacios, I Aguirrezabal, B Fernandez-Diez, L Brieva, P Villoslada","Journal of neuroimmunology 167 (1), 1-3",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14866093488147830641,3,2005
Nerve growth factor prevents inflammation and demyelination in a non human model of multiple sclerosis,"P Diaz-Villoslada, SL Hauser, N Heald, I Bartke, J Unger, CP Genain","Journal of Neuroimmunology 90 (1), 55",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=134355676693175579,3,1998
Evaluation of the 3D fractal dimension as a marker of structural brain complexity in multiple‐acquisition MRI,"S Krohn, M Froeling, A Leemans, D Ostwald, P Villoslada, C Finke, ...",Human brain mapping,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10991188996281077748,2,2019
Sustained reduction in confirmed disability progression in patients with primary progressive multiple sclerosis treated with ocrelizumab in the open-label extension period of …,"JS Wolisnky, B Brochet, X Montalban, RT Naismith, M Manfrini, M Garas, ...","Mult Scler 24, 490-1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14489668645273342916,2,2018
Optimal inter-eye difference thresholds in retinal nerve fiber layer and ganglion cell layer thickness for predicting a unilateral optic nerve lesion in multiple sclerosis: an …,"R Nolan, O Akhand, P Calabresi, F Paul, ...","MULTIPLE SCLEROSIS JOURNAL 24, 61-62",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5881756677013071628,2,2018
Anti-basal ganglia antibodies and streptococcal infection in ADHD,"S Aguilera-Albesa, N Crespo-Eguílaz, JL Del Pozo, P Villoslada, ...","Journal of attention disorders 22 (9), 864-871",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9348964267984337609,2,2018
Identification and treatment of the visual processing asymmetry in MS patients with optic neuritis: The Pulfrich phenomenon,"MJ Sobhanian, R Agarwal, E Meltzer, E Kildebeck, BS Frohman, ...","Journal of the neurological sciences 387, 60-69",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10616811161289724103,2,2018
Systems and methods for improved tractography images,"V Prchkovska, PR Rodrigues, MR Bruach, P Villoslada, ÁA de Bascarán","US Patent App. 15/291,959",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16960922208130937447,2,2018
Impact of Ocrelizumab on Cognition in Patients at Increased Risk of Progressive Disease (P1. 420),"R Benedict, J De Seze, S Hauser, L Kappos, J Wolinsky, H Zheng, ...","Neurology 90 (15 Supplement), P1. 420",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14013089156772881614,2,2018
Multiple Sclerosis Lesion Segmentation using Improved Convolutional Neural Networks.,"E Kazancli, V Prchkovska, P Rodrigues, P Villoslada, L Igual","VISIGRAPP (4: VISAPP), 260-269",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18244802395119101513,2,2018
OCT as a window to the MS brain: The view becomes slightly clearer,"AT Toosy, RT Naismith, P Villoslada","Neurology 89 (24), 2404-2405",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1491926601074553819,2,2017
Systems medicine modeling for multiple sclerosis,"E Kotelnikova, I Zubizarreta, I Pulido-Valdeolivas, P Villoslada","Current Opinion in Systems Biology 3, 125-131",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7511152446942763172,2,2017
Burden of neurological diseases in the US revealed by web searches,"R Baeza-Yates, PM Sangal, P Villoslada","PloS one 12 (5), e0178019",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4837559322601630294,2,2017
Agonists of neurotrophin receptors and their use as medicaments,"P Villoslada, A Messeguer","US Patent 9,453,047",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3345837944961856238,2,2016
Phenytoin for neuroprotection,"EH Martinez-Lapiscina, M Andorra, B Sanchez-Dalmau, P Villoslada","The Lancet Neurology 15 (9), 901-902",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8091292756245164575,2,2016
Assessing manual versus automated segmentation of the macula using Optical Coherence Tomography,"JD Oakley, I Gabilondo, C Songster, D Russakoff, A Green, P Villoslada","Investigative Ophthalmology & Visual Science 55 (13), 4790-4790",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15994114083183379267,2,2014
Retinal atrophy and brain damage in MS: a model for trans-synaptic neuronal degeneration,"I Gabilondo, A Saiz, E Martinez, E Fraga, S Llufriu, S Ortiz, C Falcon, ...","Mult Scler 18 (4 Suppl), 9-53",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10510454928016305024,2,2012
Detection of neuroinflammation through the retina by means of Raman spectroscopy and multivariate analysis,"M Marro, A Taubes, P Villoslada, D Petrov","Biophotonics: Photonic Solutions for Better Health Care III 8427, 842715",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9491678604752915283,2,2012
Use of 5′-methylthioadenosine (MTA) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection,"PV Díaz, MÁ Zaragoza, BM Bruna, FC Izquierdo, CB Lasarte, ...","US Patent 7,820,637",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16289173208930730225,2,2010
Tr1 cells in the neat sighting-pole,"S Martínez-Pasamar, I Martínez-Forero, P Villoslada","Inmunologia 27 (2), 78-84",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5024884849617308003,2,2008
The contribution of the white matter lesions to verbal memory: a voxel-by-voxel magnetic resonance analysis in multiple sclerosis,"J Sepulcre, J Goni, B Duque, N Velez de Mendizabal, B Bejarano, ...","MULTIPLE SCLEROSIS 12, S181-S182",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3766710248266742962,2,2006
Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study,"LJ Balk, D Coric, B Knier, HG Zimmermann, R Behbehani, R Alroughani, ...","Multiple Sclerosis Journal–Experimental, Translational and Clinical 5 (3 …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6905504569513387320,1,2019
Author Correction: Subgenual anterior cingulate cortex controls sadness-induced modulations of cognitive and emotional network hubs,"JP Ramirez-Mahaluf, J Perramon, B Otal, P Villoslada, A Compte","Scientific reports 8 (1), 11237",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9611426072929480051,1,2018
Time is vision: The importance of the early discovery and diagnosis of optic neuritis,"P Villoslada, EH Martinez-Lapiscina","Multiple Sclerosis Journal 23 (14), 1806-1807",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3134650811344696605,1,2017
Retinal inner nuclear layer volume: a potential new outcome measure for optic neuritis treatment trials in MS,"LJ Balk, D Coric, B Knier, H Zimmermann, R Behbehani, R Alroughani, ...","Multiple Sclerosis Journal 23, 271-273",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15089549808374839682,1,2017
Epicenters of dynamic connectivity in the adaptation of the ventral visual system,"V Prčkovska, W Huijbers, A Schultz, L Ortiz‐Teran, C Peña‐Gomez, ...","Human brain mapping 38 (4), 1965-1976",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10772765877726545994,1,2017
A Population Approach to Characterize Interferon Beta‐1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis,"A Gulati, F Bagnato, P Villoslada, NV de Mendizabal","CPT: pharmacometrics & systems pharmacology 4 (5), 295-304",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=709811108746579357,1,2015
Molecular Imaging of the human retina by Raman Spectroscopy (S26. 001),"E Martinez-Lapiscina, O Batet, A Gonzalez, A Campos, I Bilbao, D Perez, ...","Neurology 84 (14 Supplement), S26. 001",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18386981956298393108,1,2015
Intense immunosuppression for the treatment of an immune reconstitution inflammatory syndrome-like exacerbation after natalizumab withdrawal: a case report,"M Sepúlveda, S Llufriu, Y Blanco, N Solà-Valls, D La Puma, J Berenguer, ...","Journal of neurology 262 (1), 219-221",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10566143703040693047,1,2015
Retrograde axonal and neuronal degeneration of the retina in acute optic neuritis,"EH Martínez-Lapiscina, I Gabilondo, E Fraga-Pumar, S Ortiz-Perez, ...","MULTIPLE SCLEROSIS JOURNAL 20, 357-357",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3503107115887364351,1,2014
Retinal nerve fibre layer loss in multiple sclerosis is nonlinear and most rapid early in disease,"I Gabilondo, JM Gelfand, WJ Boscardin, P Villoslada, R Nolan, ...","MULTIPLE SCLEROSIS JOURNAL 19 (11), 537-538",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9284291490955791737,1,2013
Multivariate clinically isolated syndrome (CIS) risk factor study: towards individual prognosis and treatment indication in CIS,"J Kuhle, R Dobson, JP Bestwick, J Topping, G Dalla Costa, M Khademi, ...","MULTIPLE SCLEROSIS JOURNAL 19 (11), 33-34",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5822485121377282918,1,2013
Evaluating Structural Connectomics: the effect of the cortical parcellation scheme,"P Rodrigues, A Prats, D Gallardo-Pujol, P Villoslada, C Falcon, ...",Front. Neuroinform. Conference Abstract: Imaging the brain at different …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12791606279725226349,1,2013
La dimensión fractal en Imagen Médica: Desarrollos y nuevos retos,"J Jiménez, AML Estrella, FJ Esteban, J Navas, P Villoslada, JR de Miras","Proyectos de investigación, 2010-2011 [Archivo de ordenador], 225-238",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3876470532052317396,1,2013
"Autologous mesenchymal stem cell transplantation in multiple sclerosis: A randomised, double-blind, crossover with placebo phase II study","M Sepulveda, Y Blanco, S Gabilondo, I Llufriu, P Villoslada, P Marin, ...","MULTIPLE SCLEROSIS JOURNAL 18, 188-189",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18156570060888033705,1,2012
Synergistic 5′-methylthioadenosine combinations,"MAÁ Zaragozá, FJC Izquierdo, BF Díez, BM Bruna, PV Díaz","US Patent 8,236,778",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2946858507676271895,1,2012
Contribution of Trans-Synaptic Neuronal Degeneration to Retinal Atrophy in MS (P01. 161),"I Gabilondo, A Saiz, E Martínez, E Fraga, S Llufriu, S Ortiz, J Berenguer, ...","Neurology 78 (1 Supplement), P01. 161-P01. 161",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4305681296888950907,1,2012
No evidence of pancreatic autoimmunity among patients with multiple sclerosis,"JR BILBAO, P VILLOSLADA, A MARTIN‐PAGOLA, L CASTAÑO","Annals of the New York Academy of Sciences 1037 (1), 133-137",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8890159349731812385,1,2004
"Dysphagia, dysphonia and Horner's syndrome as a form of presentation of right subclavian artery aneurysm","P Díaz-Villoslada, C Nos, J Alvarez-Sabín","Revista de neurologia 24 (131), 868",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=671073653741872290,1,1996
"Antigen-specific tolerance to self-antigens in protein replacement therapy, gene therapy and autoimmunity","L Steinman, PP Ho, WH Robinson, PJ Utz, P Villoslada","Current opinion in immunology 61, 46-53",,0,2019
Correction to: Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation,"B Moreno, G Vila, B Fernandez-Diez, R Vázquez, A di Penta, O Errea, ...","Multiple Sclerosis and Demyelinating Disorders 4 (1), 3",,0,2019
Author Correction: Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease,"D Sánchez, M Castilla-Marti, O Rodríguez-Gómez, S Valero, A Piferrer, ...","Scientific reports 9 (1), 1-1",,0,2019
"Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer's disease (vol 8, 16345, 2018)","D Sanchez, M Castilla-Marti, O Rodriguez-Gomez, S Valero, A Piferrer, ...",SCIENTIFIC REPORTS 9,,0,2019
Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis,"M Andorrà, S Alba-Arbalat, A Camos-Carreras, I Gabilondo, ...",JAMA neurology,,0,2019
Predictive value of cerebrospinal fluid biomarkers on optic coherence tomography outcomes in multiple sclerosis,"R Capuano, S Llufriu, I Pulido Valdeolivas, I Zubizarreta, M Andorra, ...","MULTIPLE SCLEROSIS JOURNAL 25, 264-265",,0,2019
Cortical damage in multiple sclerosis along the course of the disease,"E Solana, E Martinez-Heras, V Montal, E Vilaplana, M Andorra, ...","MULTIPLE SCLEROSIS JOURNAL 25, 239-240",,0,2019
Inflammatory activity associated with increased rate of retinal and brain neuro-axonal injury in early MS: results from dynamic evolution in Barcelona MS-Visualpath cohort study,"I Pulido-Valdeolivas, M Andorra, D Gomez-Andres, K Nakamura, ...","MULTIPLE SCLEROSIS JOURNAL 25, 27-28",,0,2019
Predictors of quality of vision impairment in Multiple Sclerosis.,"BFS Dalmau, EH Martinez-Lapiscina, A Camos, I Pulido-Valdeolivas, ...","Investigative Ophthalmology & Visual Science 60 (9), 2280-2280",,0,2019
Sys4MS: Multiple sclerosis genetic burden score in a systems biology study of MS patients from four countries,"S Bos, I Brorson, EA Hogestol, J Saez-Rodriguez, A Uccelli, F Paul, ...","EUROPEAN JOURNAL OF NEUROLOGY 26, 159-159",,0,2019
Personalizing medical care for patients with MS: Monitoring brainstem damage by infrared oculography,"P Villoslada, AJ Green, S Galetta","Neurology 92 (20), 929-930",,0,2019
MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysis,"E Kotelnikova, NA Kiani, D Messinis, I Pertsovskaya, V Pliaka, ...","Proceedings of the National Academy of Sciences 116 (19), 9671-9676",,0,2019
HIGH-RESOLUTION HLA ALLELIC AND HAPLOTYPIC ASSOCIATION WITH MULTIPLE SCLEROSIS IN SPANISH POPULATION USING NEXT-GENERATION SEQUENCING,"G Montero-Martin, S Llufriu, M Sepulveda, T Armangue, K Osoegawa, ...","HLA 93 (5), 340-340",,0,2019
Immune tolerance in patients with Multiple Sclerosis and Neuromyelitis Optica by peptide-loaded tolerogenic dendritic cells: final results of the phase 1b clinical trial and …,"I Zubizarreta, G Florez-Grau, G Vila, R Cabezon, C Espana, M Andorrá, ...","Neurology 92 (15 Supplement), S56. 002",,0,2019
Inflammatory activity associated with increased rate of brain and retinal neuro-axonal injury in early MS The aim of this study is to address the effect of local inflammatory …,"I Pulido Valdeolivas, M Andorra, D Gomez-Andres, K Nakamura, ...",NEUROLOGY 92 (15),,0,2019
Inflammatory activity associated with increased rate of brain and retinal neuro-axonal injury in early MS The aim of this study is to address the effect of local inflammatory …,"IP Valdeolivas, M Andorra, D Gómez-Andrés, K Nakamura, S Alba-Arbalat, ...","Neurology 92 (15 Supplement), P5. 2-030",,0,2019
Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis,"A Green, P Villoslada",,,0,2019
Progressive Multiple Sclerosis Is Associated with Accelerated Inner and Outer Retinal Layer Atrophy,"ES Sotirchos, NG Caldito, A Filippatou, KC Fitzgerald, O Murphy, J Lambe, ...",ACTRIMS Forum 2019,,0,2019
Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation,"P Villoslada, G Vila, V Colafrancesco, B Moreno, B Fernandez-Diez, ...","Neurotherapeutics, 1-20",,0,2019
Remyelination: a good neuroprotective strategy for preventing axonal degeneration?,"P Villoslada, EH Martinez-Lapiscina","Brain 142 (2), 233-236",,0,2019
Prediction of combination therapies based on topological modeling of the immune signaling network in Multiple Sclerosis,"M Bernardo-Faura, M Rinas, J Wirbel, I Pertsovskaya, V Pliaka, ...","bioRxiv, 541458",,0,2019
Sustained Reduction in Confirmed Disability Progression in Patients with Primary Progressive Multiple Sclerosis Treated with Ocrelizumab in the Open-label Extension Period of …,"SL Hauser, JS Wolinsky, B Brochet, X Montalban, RT Naismith, M Manfrini, ...","Multiple sclerosis and related disorders 26, 264-265",,0,2018
Agonists of neurotrophin receptors and their use as medicaments,"P Villoslada, A Messeguer","US Patent App. 10/106,577",,0,2018
Personalizing health care in multiple sclerosis using systems medicine tools: presentation of the cytomics data from the Sys4MS project,"M Cellerino, M Pardini, C Campi, F Ivaldi, G Vila, T Berge, P Koduah, ...","MULTIPLE SCLEROSIS JOURNAL 24, 189-190",,0,2018
The Sys4MS project: personalizing health care in multiple sclerosis using systems medicine tools,"I Zubizarreta, F Ivaldi, M Rinas, E Hogestol, S Bos, T Berge, P Koduah, ...","MULTIPLE SCLEROSIS JOURNAL 24, 459-459",,0,2018
Brain complexity and damage in patients with multiple sclerosis using fractal analysis: a new imaging outcome for monitoring MS severity,"E Roura, G Maclair, EH Martinez-Lapiscina, M Andorrà, P Villoslada","MULTIPLE SCLEROSIS JOURNAL 24, 210-210",,0,2018
Combined walking outcome measures identify clinically meaningful response to prolonged-release fampridine,"N Sola-Valls, Y Blanco, M Sepúlveda, S Llufriu, EH Martínez-Lapiscina, ...","Therapeutic advances in neurological disorders 11, 1756286418780007",,0,2018
"Effect of Ocrelizumab on Relapse Rate, and Disability Progression and Improvement in Relapsing Multiple Sclerosis Patients in the Open-Label Extension of the Pooled OPERA Trials","B Brochet, SL Hauser, X Montalban, R Naismith, JS Wolinsky, M Manfrini, ...","EUROPEAN JOURNAL OF NEUROLOGY 25, 322-322",,0,2018
Optimal Inter-Eye Difference Thresholds in Retinal Nerve Fiber Layer and Ganglion Cell Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis: An …,"R Nolan, O Akhand, P Calabresi, F Paul, EHM de Lapiscina, A Petzold, ...","Neurology 90 (15 Supplement), P2. 160",,0,2018
Correction to: the disruption of mitochondrial axonal transport is an early event in neuroinflammation,"O Errea, B Moreno, A Gonzalez-Franquesa, PM Garcia-Roves, ...","Journal of neuroinflammation 14 (1), 206",,0,2017
"The disruption of mitochondrial axonal transport is an early event in neuroinflammation (vol 12, 152, 2015)","O Errea, B Moreno, A Gonzalez-Franquesa, PM Garcia-Roves, ...",JOURNAL OF NEUROINFLAMMATION 14,,0,2017
Mapping neuroeconomic decisions in multiple sclerosis: a connectivity approach,"S Llufriu, E Solana, M Sepulveda, D Levi, E Martinez-Heras, M Andorra, ...","MULTIPLE SCLEROSIS JOURNAL 23, 247-247",,0,2017
Ganglion cell layer atrophy starts one week after onset of acute optic neuritis and progress over 18 months,"S Alba-Arbalat, A Camos-Carreras, I Pulido-Valdeolivas, I Gabilondo, ...","MULTIPLE SCLEROSIS JOURNAL 23, 11-12",,0,2017
Harnessing electronic medical records to advance research on multiple sclerosis,"V Damotte, A Lizee, M Tremblay, A Agrawal, P Khankhanian, ...","MULTIPLE SCLEROSIS JOURNAL 23, 128-129",,0,2017
Brain atrophy rates in multiple sclerosis changes along disease course are sensitive to image processing method: not ready for NEDA-4 yet?,"M Andorra, K Nakamura, EJ Lampert, I Pulido-Valdeolivas, S Llufriu, ...","MULTIPLE SCLEROSIS JOURNAL 23, 10-11",,0,2017
Retinal layer segmentation in multiple sclerosis: a systematic review and meta–analysis,"LJ Balcer, PA Calabresi, F Costello, TC Frohmann, EM Frohmann, ...",,,0,2017
Early retinal atrophy predicts long-term visual impairment after acute optic neuritis,"BS Dalmau, EH Martinez-Lapiscina, RT Torres, S Ortiz-Perez, ...","Investigative Ophthalmology & Visual Science 58 (8), 5122-5122",,0,2017
Agonists of neurotrophin receptors and their use as medicaments,"P Villoslada, A Messeguer","US Patent App. 15/261,410",,0,2017
Retinal Nerve Fiber Layer Thickness defines Multiple Sclerosis Patients at Risk of Future Disease Progression (S33. 003),"P Villoslada, A Green, JL Keltner, R Meinert, D Silva, M Van Hoef, ...","Neurology 88 (16 Supplement), S33. 003",,0,2017
Modeling the Dynamics of the Immune Response,"E Abad, P Villoslada, J García‐Ojalvo",Systems Biology 6,,0,2017
Sampling stability and processing parameter-dependent characteristics of the 3D fractal dimension as a marker of structural brain complexity in magnetic resonance images,"S Krohn, M Froeling, A Leemans, D Ostwald, J Jiménez, P Villoslada, ...","bioRxiv, 124206",,0,2017
Revising the Advised Protocol for Optical coherence tomography Study Terminology and Elements (APOSTEL): from recommendations to formal guidelines,"A Cruz-Herranz, A Aytulun, L Balk, O Maier, H Zimmermann, N Feltgen, ...","Multiple Sclerosis Journal, 566-568",,0,2017
Comparison of Automated Retinal Segmentation across OCT Devices using Independent Analysis Software,"JD Oakley, M Andorra, EH Martinez-Lapiscina, D Russakoff, P Villoslada","Investigative Ophthalmology & Visual Science 57 (12), 5956-5956",,0,2016
The role of multifocal visual evoked potentials in understanding disability in multiple sclerosis,"EH Martinez-Lapiscina, AI Tercero-Uribe, S Alba-Arbalat, N Sola-Valls, ...","MULTIPLE SCLEROSIS JOURNAL 22, 465-466",,0,2016
Optical coherence tomography detects significant retinal atrophy in progressive MS which is modulated by disease modifying therapies,"S Saidha, J Button, E Martinez-Lapiscina, R Nolan, A Brandt, D Conger, ...","MULTIPLE SCLEROSIS JOURNAL 22, 366-367",,0,2016
Agonistas de receptores de neurotrofinas y su uso como medicamentos,"P Villoslada, A Messeguer",,,0,2016
A Phase 1b Clinical Trial with Tolerogenic Dendritic Cells for Multiple Sclerosis and Neuromyelitis Óptica (P2. 159),"I Zubizarreta, D Benitez, V Sara, JA Arnaiz, A Saiz, P Villoslada","Neurology 86 (16 Supplement), P2. 159",,0,2016
Retinal Atrophy Measured by Optical Coherence Tomography Predicts Disability Progression in Multiple Sclerosis (S45. 007),"E Martinez-Lapiscina, S Arnow, J Wilson, S Saidha, J Preiningerova, ...","Neurology 86 (16 Supplement), S45. 007",,0,2016
Antigen-specific therapy for the treatment of neuromyelitis optica,"I Zubizarreta, P Villoslada, D Benitez-Ribas","Drugs of the Future 41 (2), 131-136",,0,2016
Drug Trials in Neuroprotection,"EH Martínez-Lapiscina, B Sanchez-Dalmau, P Villoslada","Optical Coherence Tomography in Multiple Sclerosis, 171-184",,0,2016
Exploring Anti-correlated Resting State BOLD Signals Through Dynamic Functional Connectivity and Whole-brain Computational Modeling,"M Demirtas, M Gilson, JD Murray, D Popovic, E Vieta, L Pintor, ...","bioRxiv, 085274",,0,2016
First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases,"A Borroto Revuelta, D Reyes-Garau, M Jiménez, E Carrasco, B Moreno, ...",,,0,2016
Trans Neuronal Retrograde Degeneration to OCT in Central Nervous System Diseases,"BF Sanchez-Dalmau, R Torres-Torres, J Keller, EH Martínez-Lapiscina, ...","OCT in Central Nervous System Diseases, 205-214",,0,2016
RS-fMRI Data Analysis for Identification of Changes in Functional Connectivity Networks of Bi-polar Patients,"T Boshkovski, I Ivanoska, K Trivodaliev, S Kalajdziski, P Villoslada, ...","International Conference on ICT Innovations, 235-244",,0,2015
Molecular imaging of In vivo human retina by Raman spectroscopy: basis and MS and healthy voluntaries profile,"EH Martinez-Lapiscina, O Batet, I Torre, A Gonzalez, A Campos, I Bilbao, ...","MULTIPLE SCLEROSIS JOURNAL 21, 627-627",,0,2015
Clinically meaningful change of walking assessments in patients with multiple sclerosis treated with PR-fampridine,"N Sola-Valls, Y Blanco, M Sepulveda, S Llufriu, EH Martinez-Lapiscina, ...","MULTIPLE SCLEROSIS JOURNAL 21, 126-126",,0,2015
Decision-making in multiple sclerosis: a neuroeconomics approach,"M Sepulveda, B Fernandez, EH Martinez-La Piscina, A Saiz, D Levy, ...","MULTIPLE SCLEROSIS JOURNAL 21, 231-231",,0,2015
Visual field impairment as a marker of diffuse damage in multiple sclerosis,"S Ortiz-Perez, B Sanchez-Dalmau, R Torres-Torres, M Andorra, N Sola, ...","MULTIPLE SCLEROSIS JOURNAL 21, 626-627",,0,2015
Structural connectivity and cognitive performance in multiple sclerosis,"S Llufriu, E Martinez-Heras, N Sola-Valls, M Sepulveda, F Varriano, ...","MULTIPLE SCLEROSIS JOURNAL 21, 645-646",,0,2015
Dyschromatopsia in multiple sclerosis points to retinal ganglion cell damage,"E Lampert, M Andorra, R Torres-Torres, S Ortiz-Perez, S Llufriu, ...","MULTIPLE SCLEROSIS JOURNAL 21, 344-345",,0,2015
The disruption of mitochondrial axonal transport is an early event in neuroinflammation,"O Errea Lorenzo, B Moreno, A González Franquesa, PM García-Roves, ...","Journal of Neuroinflammation, 2015, vol. 12, p. 152",,0,2015
Optical coherence tomography in a multi-center setting: quality control issues,"A Petzold, LJ Balcer, PA Calabresi, F Costello, EM Frohman, AJ Green, ...","Optical Coherence Tomography in Neurologic Diseases, 198",,0,2015
Retinal inflammation in multiple sclerosis revealed by optical coherence tomography and ophthalmoscopy,"EH Martinez-Lapiscina, B Sanchez-Dalmau, P Villoslada","Optical Coherence Tomography in Neurologic Diseases, 176",,0,2015
Molecular Imaging of the human retina by Raman Spectroscopy (I1-1B),"E Martinez-Lapiscina, O Batet, A Gonzalez, A Campos, I Bilbao, D Perez, ...","Neurology 84 (14 Supplement), I1-1B",,0,2015
"RNFL as a Surrogate Outcome Marker in Patients with Multiple Sclerosis: Design of the OCTiMS study, Baseline Characteristics and OCT Test Reproducibility (P7. 224)","P Calabresi, F Barkhof, A Green, R Kardon, F Paul, J Sastre-Garriga, ...","Neurology 84 (14 Supplement), P7. 224",,0,2015
Contextual Diffusion Image Post-processing,"V Prckovska, M Andorrà, P Villoslada, E Martinez-Heras, R Duits, D Fortin, ...",,,0,2015
The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS.,"E Hernández Martinez Lapiscina, E Fraga Pumar, I Gabilondo, ...","BMC Research notes, 2014, vol. 7, num. 910",,0,2014
Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis.,"S Llufriu Duran, M Sepúlveda, Y Blanco, P Marín, B Moreno, J Berenguer, ...","PLoS One, 2014, vol. 9, num. 12, p. e113936",,0,2014
Closing the Clinical-Radiological Paradox in the Visual Pathway in Multiple Sclerosis,P Villoslada,,,0,2014
Sectorial macular retinal ganglion cell layer thinning caused by retrograde degeneration of the visual pathway,"BFS Dalmau, J Keller, P Villoslada","Investigative Ophthalmology & Visual Science 55 (13), 6218-6218",,0,2014
"Is optic neuritis incidence rising? Evidences from an epidemiological study in Barcelona, Spain 2008-2012","EH Martinez-Lapiscina, E Fraga-Pumar, X Pastor, M Gómez, A Conesa, ...","Investigative Ophthalmology & Visual Science 55 (13), 6086-6086",,0,2014
"Is Optic Neuritis Incidence Rising? Evidence from an Epidemiological Study in Barcelona, Spain 2008-2012 (P2. 292)","E Martínez-Lapiscina, E Fraga, X Pastor, M Gómez, A Conesa, ...","Neurology 82 (10 Supplement), P2. 292",,0,2014
Modeling Anti-CD20 Mediated B Cell Depletion Indicates The Role Of Treg In The Response To Therapy In MS (P1. 163),"P Villoslada, S Martinez-Pasamar, E Abad, B Moreno, NV de Mendizabal, ...","Neurology 82 (10 Supplement), P1. 163",,0,2014
Color Vision Impairment Is Associated with Disease Severity in Multiple Sclerosis (P2. 263),"E Martínez-Lapiscina, S Ortiz-Pérez, E Fraga, E Martínez-Heras, ...","Neurology 82 (10 Supplement), P2. 263",,0,2014
Correction: Predicting Relapsing-Remitting Dynamics in Multiple Sclerosis Using Discrete Distribution Models: A Population Approach,"NV De Mendizabal, MM Hutmacher, IF Troconiz, J Goñi, P Villoslada, ...",PloS one 9 (1),,0,2014
Association of Multiple Sclerosis Susceptibility Variants and Early Attack Location in the CNS,"P Bacchetti, E Waubant, EM Mowry, RF Carey, MR Blasco, J Pelletier, ...",,,0,2013
Multiple Sclerosis Susceptibility Genes: Associations with Relapse Severity and Recovery,"P Bacchetti, E Waubant, EM Mowry, RF Carey, MR Blasco, J Pelletier, ...",,,0,2013
Multicentre inter-rater reliability of retinal layer segmentation using spectral-domain optical coherence tomorgraphy (OCT),"T Oberwahrenbrock, GL Traber, I Gabilondo, R Nolan, C Songster, L Balk, ...","MULTIPLE SCLEROSIS JOURNAL 19 (11), 191-191",,0,2013
Implementation of a clinical monitoring program by Telemedicine in patients with Multiple Sclerosis,"N Sola, MD Blanco, MD Llufriu, M Sepúlveda, MD Gabilondo, ...","MULTIPLE SCLEROSIS JOURNAL 19 (11), 360-360",,0,2013
Genetic Associations of Clinical Progression in Multiple Sclerosis,"S Lulu, E Mowry, R Carey, M Blasco, J Pelletier, P Duquette, P Villoslada, ...",Annals of Neurology 74,,0,2013
Colour vision impairment regardless of optic neuritis is associated with disease severity in multiple sclerosis,"EH Martinez-Lapiscina, S Ortiz-Perez, E Fraga-Pumar, E Martinez-Heras, ...","MULTIPLE SCLEROSIS JOURNAL 19 (11), 294-294",,0,2013
Genetic markers for the prognosis of multiple sclerosis,"PV Díaz, RP Urtasun, JS Bernad, LS Buela, AM Martínez","US Patent App. 12/809,726",,0,2013
Association between retinal impairment and disease severity in Multiple Sclerosis,"S Ortiz-Perez, E Martinez-Lapiscina, I Gabilondo, E Fraga-Pumar, ...","Investigative Ophthalmology & Visual Science 54 (15), 2347-2347",,0,2013
Corneal nerve morphology: a non-invasive surrogate of nerve fibre damage and repair in chemotherapy-associated peripheral neuropathy,"BS Dalmau, ML Moreno, R Torres, S Ortiz-Perez, D Vela, E Fraga, ...","Investigative Ophthalmology & Visual Science 54 (15), 530-530",,0,2013
Retinal Inflammation as a Biomarker of Disease Activity in Multiple Sclerosis,"E Martinez-Lapiscina, S Ortiz-Perez, I Gabilondo, E Fraga-Pumar, A Saiz, ...",NEUROLOGY 80,,0,2013
Cognitive Performance and Brain Integrity in Multiple Sclerosis: A Diffusion Tensor Imaging Study (P06. 112),"S Llufriu, E Martinez-Heras, C Gabilondo, YB Morgado, F Juan, C Falcon, ...","Neurology 80 (7 Supplement), P06. 112-P06. 112",,0,2013
Retinal Inflammation as a Biomarker of Disease Activity in Multiple Sclerosis (P04. 133),"E Martínez-Lapiscina, S Ortiz-Perez, I Gabilondo, E Fraga-Pumar, A Saiz, ...","Neurology 80 (7 Supplement), P04. 133-P04. 133",,0,2013
Predicting Relapsing-Remitting Dynamics in Multiple Sclerosis,"N Velez de Mendizabal, MM Hutmacher, IF Troconiz, J Goni, P Villoslada",,,0,2013
Systems Biology for the Study of Multiple Sclerosis,"P Villoslada, L Steinman","Multiple Sclerosis Immunology, 257-268",,0,2013
ESCLEROSIS MÚLTI LE,"CR Tello, LG López, B Bejarano, V Segura, P Villoslada, IM León, ...",,,0,2013
Re: Errors in the Editorial by Christensen and Giovannoni [HERVs: have we been here before? MSJ 18 (12) 1670–1672],"GA Caputo, P Morand, AB Lang, S Sotgiu, K Ruprecht, P Rieckmann, ...","Multiple Sclerosis Journal 19 (6), 831-832",,0,2013
Methylthioadenosine promotes neuroprotection for inflammatory and excitotoxic brain diseases,"B Moreno, P Di Alessandra, B Fernandez, O Errea, I Agirrezabal, ...","JOURNAL OF NEUROIMMUNOLOGY 253 (1-2), 173-174",,0,2012
Multicentre reliability of intra-retinal layer segmentation,"T Oberwahrenbrock, I Gabilondo, R Nolan, C Songster, GL Traber, L Balk, ...","MULTIPLE SCLEROSIS JOURNAL 18, 494-495",,0,2012
Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study.,"S Llufriu Duran, Y Blanco Morgado, E Martinez Heras, J Casanova Molla, ...","PLoS One, 2012, vol. 7, num. 5, p. 1-7",,0,2012
Neurotrophin Peptidomimetics Activate TrkA/B Signaling and Display Neuroprotective Effects in Neuroinflammation and Neurodegeneration (P07. 091),"P Villoslada, B Moreno, V Colafrancesco, E Giralt, M Teixido, JM Frade, ...","Neurology 78 (1 Supplement), P07. 091-P07. 091",,0,2012
"Raman Spectroscopy Analysis of the Retina Reveals Changes in Glutamate, N-Acetyl-Aspartate, NADH and Phosphatidylcholine in Neuroinflammation (P01. 166)","P Villoslada, M Marro, A Taubes, B Moreno, D Petrov","Neurology 78 (1 Supplement), P01. 166-P01. 166",,0,2012
Neuroprotective properties of 5'-methylthioadenosine,PV Diaz,"US Patent App. 13/376,894",,0,2012
Association Between Clinical And Radiological Features And Optical Coherence Tomography (oct) Measures In Multiple Sclerosis (ms),"S Ortiz-Perez, I Gabilondo, E Fraga, A Saiz, JJ Molina, S Llufriu, ...","Investigative Ophthalmology & Visual Science 53 (14), 3909-3909",,0,2012
A SOFTWARE PLATFORM TO ANALYZE MR IMAGES BASED ON 3D FRACTAL DIMENSION-Application in Neurodegenerative Diseases,"J Jiménez, AM López, FJ Esteban, P Villoslada, J Navas, JR de Miras",International Joint Conference on Biomedical Engineering Systems and …,,0,2012
A dynamics analysis of antigen specific T cells during brain autoimmunity supports the role of regulatory T cells in disease outcome,"S Martinez Pasamar, E Abad Adán, B Moreno, N Velez de Mendizabal, ...",Elsevier,,0,2012
A SOFTWARE PLATFORM TO ANALYZE MR IMAGES BASED ON 3D FRACTAL DIMENSION,"J Jiménez, AM López, FJ Esteban, P Villoslada, J Navas, JR de Miras",,,0,2012
Guía de uso adecuado de modelos animals para el desarrollo de terapias en esclerosis múltiple| Guidelines on the appropriate use of animal models for developing therapies in …,"B Moreno, C Espejo, L Mestre, M Suardíaz, D Clemente, ...",Viguera Editores,,0,2012
AXONAL MITOCHONDRIAL DYSFUNCTION IN AN IN VITRO MODEL OF NEUROINFLAMMATION,"O Errea, P Villoslada","GLIA 59, S136-S136",,0,2011
NEUROHISTOPATHOLOGICAL CHARACTERIZATION OF ADOPTIVE TRANSFER EAE IN C57BL6/J MICE,"F Mannara, T Valente, B Moreno, P Villoslada, A Saiz, F Graus","GLIA 59, S143-S143",,0,2011
ROLE OF METHYLTHIOADENOSINE IN PROMOTING REMYELINATION AND PREVENTING DEMYELINATION: BASES FOR THE TREATMENT OF MULTIPLE SCLEROSIS,"B Moreno, A Di Penta, B Fernandez, N Escala, P Villoslada","GLIA 59, S92-S92",,0,2011
Role of methylthioadenosine in promoting remyelination and preventing demyelination: bases for the treatment of multiple sclerosis,"B Moreno Bruna, A Di Penta, B Fernandez, N Escala, P Villoslada","MULTIPLE SCLEROSIS JOURNAL 17, S208-S208",,0,2011
Association of MS Susceptibility Variants and Early Attack Location: T1713,"E Mowry, J Pelletier, M Blasco, P Duquette, P Villoslada, PA Gourraud, ...",Annals of Neurology 70,,0,2011
NEUROPSYCHOLOGICAL IMPAIRMENT: IMPACT ON THE EARLY DISEASE COURSE AND TREATMENT DECISIONS: FW 3-2,P Villoslada,European Journal of Neurology 18,,0,2011
Modeling Type I interferon pathway for the study of Multiple Sclerosis,"I Pertsovskaya, N Domedel-Puig, J Garcia-Ojalvo, P Villoslada",Department of Bioengineering and Bioinformatics of MV Lomonosov Moscow State …,,0,2011
Increased expression of cystine/glutamate antiporter in multiple sclerosis,"O Pampliega Ormaetxea, M Domercq García, FN Soria Lannes, ...",BioMed Central,,0,2011
Using 2D correlation and multivariate analysis combined with plasmonic effects to expand the use of Raman microspectroscopy in biomedical applications,"M Marro, S Raj, S Rao, A Taubes, P Villoslada, D Petrov","European Conference on Biomedical Optics, 80871H",,0,2011
3-oxopiperazinium derivatives as agonists of nerve growth factor receptors and their use as medicaments,"B Moreno, P Villoslada, J Messeguer, G Navarro, Á Messeguer Peypoch",,,0,2011
New peptoid agonists of nerve growth factor receptor and their use as medicaments,"B Moreno, P Villoslada, G Navarro, J Messeguer, Á Messeguer Peypoch",,,0,2011
3-Oxopiperazinium derivatives as agonists of nerve growth factor and their use as medicaments,"B Moreno, P Villoslada, J Messeguer, G Navarro, Á Messeguer Peypoch",,,0,2011
Some Multiple Sclerosis Susceptibility Genes Are Associated with Relapse Severity and Recovery,"EM Mowry, MR Blasco, J Pelletier, P Duquette, P Villoslada, I Malikova, ...","NEUROLOGY 76 (9), A187-A188",,0,2011
HLA-DRB1 en pacientes caucásicos con neuromielitis óptica,"Y Blanco, G Ercilla-González, S Llufriu, B Casanova-Estruch, ...","Rev. neurol.(Ed. impr.) 53 (3), 146-152",,0,2011
Axonal mitochondrial dysfunction in an in vitro model of neuroinflammation,"E Oihana, DP Alessandra, M Beatriz, E Nagore, F Begona, V Pablo","JOURNAL OF NEUROIMMUNOLOGY 228 (1-2), 30-30",,0,2010
CNS white matter autoimmunity,V Pablo,"JOURNAL OF NEUROIMMUNOLOGY 228 (1-2), 2-3",,0,2010
Effector and regulatory T cell dynamics in autoimmunity,"M Sara, V Pablo","JOURNAL OF NEUROIMMUNOLOGY 228 (1-2), 105-105",,0,2010
Modeling type I IFN pathway in macrophages: Implications for immunotherapy,"P Inna, DP Nuria, GO Jordi, V Pablo","JOURNAL OF NEUROIMMUNOLOGY 228 (1-2), 115-115",,0,2010
A gene expression signature in blood predicts disease course in patients with multiple sclerosis,"A Ion, P Ricardo, V Pablo","JOURNAL OF NEUROIMMUNOLOGY 228 (1-2), 65-65",,0,2010
NGF-like small molecules play a protective role in neurodegenerative disorders: In vitro and in vivo application,"C Valeria, M Beatriz, N Venrell Gloria, F Diez Begona, E Solans Nagore, ...","JOURNAL OF NEUROIMMUNOLOGY 228 (1-2), 213-213",,0,2010
Developing retina spectroscopy for the study of neuroinflammation,"T Alice, M Sanchez Monica, B Stefan, M Beatriz, F Diez Begona, ...","JOURNAL OF NEUROIMMUNOLOGY 228 (1-2), 11-11",,0,2010
Multiple sclerosis gene network analysis,"DB Leticia, V Pablo, WP Dennis, EJ Francisco","JOURNAL OF NEUROIMMUNOLOGY 228 (1-2), 50-50",,0,2010
Neuroprotective activity of methylthioadenosine for the treatment of Multiple Sclerosis and other neurological diseases,"V Pablo, DP Alessandra, K Martin, M Carlos, C Valentin, L Iciar, A Jordi, ...","JOURNAL OF NEUROIMMUNOLOGY 228 (1-2), 207-207",,0,2010
Mechanisms of action of Methylthioadenosine: pathways implicated in neuroprotection in models of Multiple Sclerosis and other neurological diseases,"B Moreno, A Di Penta, M Kerschensteiner, C Matute, V Ceña, I Lopez, ...","Journal of translational medicine 8 (S1), P28",,0,2010
OP39. 02: MRI cerebral fractal dimension analysis in preterm infants with and without intrauterine growth restriction,"M Sanz‐Cortes, N Padilla, J Ruiz de Miras, FJ Esteban, P Villoslada, ...","Ultrasound in Obstetrics & Gynecology 36 (S1), 165-165",,0,2010
Memantine in the Treatment of Neurological Diseases: Lessons from Multiple Sclerosis,"G Arrondo, M Alegre, P Villoslada","The European Neurological Journal 2 (2), 1",,0,2010
Neuroprotective Activity of Methylthioadenosine for the Treatment of Multiple Sclerosis and Other Neurological Diseases,"P Villoslada, A di Penta, M Kerschensteiner, H Pellkofer, C Matute, ...","NEUROLOGY 74 (9), A483-A483",,0,2010
Color Vision and High-Resolution OCT Are Highly Sensitive for Detecting Anterior Visual Pathway Abnormalities in Multiple Sclerosis,"AJ Green, J Gelfand, A Cuneo, P Villoslada","NEUROLOGY 74 (9), A99-A99",,0,2010
T3 favours myelin repair in the non-human primate model for multiple sclerosis (marmoset Callithrix Jacchus),"G D'Intino, M Fernandez, L Lorenzini, T Taglioni, G Perretta, ...","MULTIPLE SCLEROSIS 15 (9), S90-S90",,0,2009
Marcadores genéticos para el pronóstico de la esclerosis múltiple,"RP Urtasun, JS Bernad, PV DÍAZ, AM MARTÍNEZ, LS BUELA",,,0,2009
82 CML–Multiple Sclerosis 2012 Vol 4 No 3,"P Villoslada, S Baranzini","Proc Natl Acad Sci USA 106, 5842-7",,0,2009
The relapsing dynamics of multiple sclerosis depends on control properties of peripheral immune tolerance,"N Velez de Mendizabal, J Bragard, J Goni, I Martinez-Forero, ...","JOURNAL OF NEUROIMMUNOLOGY 203 (2), 132-132",,0,2008
Role of methyltioadenosine for the treatment of multiple sclerosis,"P Villoslada, Fernandez-Diez, begona, B Moreno, R Palacios","JOURNAL OF NEUROIMMUNOLOGY 203 (2), 141-141",,0,2008
Pharmacogenetics in MS and future implications,P Villoslada,European Journal of Neurology 15,,0,2008
A computational analysis of protein-protein interaction networks in neurodegenerative diseases,"J Goñi Cortés, FJ Esteban Ruiz, N Vélez de Mendizábal, J Sepulcre, ...",Biomed Central,,0,2008
Quantitative and qualitative RT-PCR detection of the multiple sclerosis associated retrovirus in populations of different ethnicity,"G Arru, V Astone, G Mameli, ML Fois, A Sanna, A Dolei, C Serra, Y Huang, ...","MULTIPLE SCLEROSIS 13, S144-S144",,0,2007
Corrigendum to “Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans”[J. Neuroimmunol. 179 (2006) 108–116],"M Ban, D Booth, R Heard, G Stewart, A Goris, K Vandenbroeck, B Dubois, ...","Journal of Neuroimmunology 189 (1), 175-176",,0,2007
Pharmacogenetic study of interferon beta treatment in multiple sclerosis. A candidate gene studyCommunications libres orales,"N Couturier, E Schmit, PA Gourraud, M Comabella, X Montalban, F Weber, ...","Revue Neurologique 163 (6-7), 722-723",,0,2007
IL-10 suppressor activity and Tr1 cell function are impaired in multiple sclerosis,"P Villoslada, R Garcia-Munoz, S Inoges, A Lopez, R Palacios, J Sepulcre, ...","NEUROLOGY 68 (12), A396-A396",,0,2007
MS White Matter Lesion Topography Defines the White Matter Tracks Involved in Human Verbal Memory,"J Sepulcre, J Masdeu, J Sastre-Garriga, J Goñi, N Mendizábal, B Duque, ...","NEUROLOGY 68 (12), A330-A330",,0,2007
Brain pathways in human working memory: Evidence from white matter lesions of multiple sclerosis,"J Sepulcre, J Masdeu, J Goni, NV de Mendizabal, C Barbosa, MA Pastor, ...","NEUROLOGY 68 (12), A55-A56",,0,2007
Therapeutic opportunities for trophic factors in brain inflammation,"B Moreno, P Villoslada","Current Pharmaceutical Analysis 3 (1), 7-15",,0,2007
A double-blind European Multicenter Study Evidences envelope protein from Human Endogenous Retrovirus W (MSRV-ENV or Syncytin) in serum from 73% of MS patients without …,"C Bernard, I Stefas, S Sotgiu, P Rieckmann, M Saresella, R Mancuso, ...","JOURNAL OF NEUROVIROLOGY 13, 24-25",,0,2007
Quantitative anti-MOG Serumtiter sind nicht prädiktiv für Krankheitsaktivität und-progression beim ersten Ereignis der Multiplen Sklerose–Ergebnisse einer ELISA-Studie,"T Menge, PH Lalive, M Tintore, HC von Büdingen, P Villoslada, ...","Aktuelle Neurologie 34 (S 2), P485",,0,2007
Multiple Sclerosis and HERV-W/MSRV: A Multicentric Study. Int J Biomed Sci.,"G Arru, G Mameli, V Astone, C Serra, Y Huang, H Link, E Fainardi, ...",,,0,2007
An evaluation of quantitative env and qualitative pol rt-pcr detection of the multiple sclerosis (MS)-associated retrovirus in Europe,"G Arru, V Astone, G Mameli, A Sanna, A Dolei, C Serra, H Link, ...","XXXVIII CONGRESS ITALIAN NEUROLOGICAL SCIENCES 28, s198-s198",,0,2007
Polymorphisms in interferon-induced genes help to predict response to interferon-beta therapy in multiple sclerosis,"D Brassat, M Comabella, S Baranzini, S Caillier, P Villoslada, C Arnaud, ...","MULTIPLE SCLEROSIS 12, S71-S71",,0,2006
Longitudinal cognitive changes and disease progression in multiple sclerosis,"B Duque, J Sepulcre, J Gallego, J Goni, P Villoslada","MULTIPLE SCLEROSIS 12, S142-S142",,0,2006
Clinical validation of MsdiagTM test for predicting Multiple Sclerosis activity.,"P Villoslada, J Sepulcre, B Duque, J Goni, B Fernandez, C Lyonnais, ...",,,0,2006
Grey matter atrophy in the visual pathway of multiple sclerosis patients,"J Sepulcre, J Gallego, J Goni, N Velez de Mendizabal, P Villoslada","MULTIPLE SCLEROSIS 12, S176-S176",,0,2006
A system biology approach to the immune system network reveals functional differences in health and Multiple Sclerosis,"P Villoslada, R Palacios, J Goni, N Velez, J Sepulcre","JOURNAL OF NEUROIMMUNOLOGY 178, 79-79",,0,2006
Preclinical studies with methylthioadenosine for the treatment of multiple sclerosis,"B Moreno, J Sepulcre, C Berasain, F Corrales, M Avila, P Villoslada","MULTIPLE SCLEROSIS 12, S105-S105",,0,2006
Lower amplitude of the auditory amplitude modulation-following responses in multiple sclerosis patients with fatigue,"B Duque, J Sepulcre, M Alegre, M Valencia, J Iriarte, J Artieda, ...","MULTIPLE SCLEROSIS 12, S151-S151",,0,2006
Retinal Periphlebitis and Optic Nerve Fiber Layer Atrophy Is Associated with Disease Activity in Multiple Sclerosis,"P Villoslada, M Murie, J Sepulcre, A Garica-Layana, A Salinas",Neurology 66 (5),,0,2006
Inflammatory Disorders of the Nervous System,P Villoslada,"Archives of Neurology 63 (2), 297-297",,0,2006
Genome-wide pharmacogenomic analysis of the response to interferon-beta in multiple sclerosis,"EH Byun, SJ Caillier, G Haskin-Fernald, X Montalban, P Villoslada, ...","ANNALS OF NEUROLOGY 60, S31-S31",,0,2006
Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.,"L Ph, T Menge, C Delarasse, B Della Gaspera, D Pham-Dinh, P Villoslada, ...",,,0,2006
"edited by Alireza Minagar, MD, and J. Steven Alexander, PhD, 348 pp, with illus, $155, ISBN 1-588-29-424-2, Totowa, NJ, Humana Press, 2005. This book sets out to offer a summary",P Villoslada,,,0,2006
Acquired regulatory function (Tr1) is impaired in multiple sclerosis patients,"R Garcia-Munoz, S Inoges, A Lopez, R Palacios, J Sepulcre, JP Cabello, ...","JOURNAL OF NEUROIMMUNOLOGY 154 (1-2), 224-224",,0,2004
Interferon-gamma gene expression levels are reduced in peripheral blood mononuclear cells in multiple sclerosis,"R Palacios, B Fernandez-Diez, J Sepulcre, J Goni, P Villoslada","JOURNAL OF NEUROIMMUNOLOGY 154 (1-2), 188-188",,0,2004
A methylation-inhibitor suppresses T cell activation and prevents experimental autoimmune encephalomyelitis,"B Moreno, M Avila, F Corrales, B Fernandez, P Villoslada","JOURNAL OF NEUROIMMUNOLOGY 154 (1-2), 85-85",,0,2004
Gene expression profiling predicts response to therapy in IFN-beta treated relapsing-remitting multiple sclerosis patients,"M Comabella, P Mousavi, J Rio, S Caillier, A Stillman, P Villoslada, ...","MULTIPLE SCLEROSIS 10 (7032), S109-S109",,0,2004
Human endogenuous retroviral particles in MS samples from different European MS populations and in relation to clinical activity,"G Arru, M Fois, M Pugliatti, A Sanna, G Rosati, A Dolei, C Serra, G Mameli, ...",20th Congress of the European Committee for Treatment and Research in …,,0,2004
Nerve growth factor is a tissue-specific regulatory cytokine in CNS inflammation,"C Genain, P Villoslada","FASEB JOURNAL 17 (4), A346-A346",,0,2003
Pharmacogenomic analysis of immunotherapy in multiple sclerosis.,"U Sriram, L Barcellos, P Villoslada, J Rio, A Begovich, S Baranzini, ...","FASEB JOURNAL 16 (5), A1047-A1047",,0,2002
"Autoantibodies against conformational epitopes of myelin oligodendrocyte, glycoprotein play a major role in disease expression in marmoset experimental allergic encephalomyelitis","HC von Budingen, CP Genain, P Villoslada, SL Hauser","ANNALS OF NEUROLOGY 50 (3), S26-S26",,0,2001
Cognitive imparirment with valproate treatment,"C Borras, X Montalban, P Villoslada","Medicina clínica 115 (20), 799",,0,2000
Brief Definitive Report Human Nerve Growth Factor Protects Common Marmosets against Autoimmune Encephalomyelitis by Switching the Balance of T Helper Cell Type 1 and 2 …,"P Villoslada, SL Hauser, I Bartke, J Unger, N Heald, D Rosenberg, ...",,,0,2000
"Dementia, parkinsonism and myoclonic seizures in a 58-year-old woman","C Molina, P Díaz-Villoslada, M Tintoré, J Serena, A Ortega","Revista de neurologia 24 (129), 574-579",,0,1996
Utilidad de la RM craneal seriada en las mielitis aisladas para el diagnostico de esclerosis multiple,"P Diaz Villoslada, A Rovira, E Grive, J Montalban","MEDICINA CLINICA 105, 278-278",,0,1995
Mapping the brain pathways of declarative verbal memory: Evidence from,"J Sepulcre, CM Joseph, J Sastre-Garriga, J Goñi, N Vélez-de-Mendizábal, ...","learning 24, 1019-25",,0,1974
Lexical access changes in patients with multiple sclerosis: A two-year follow-up study,"MS Barcelona, J Goñi, NV de Mendizabal, P Villoslada",,,0,0
Use of non-mydriatic wide-field retinography for periphlebitis detection in patients with multiple sclerosis,"R Torres-Torres, E Fraga-Pumar, EH Martínez-Lapiscina, P Villoslada, ...",,,0,0
The structural disconnectome of the MS brain,"V Prčkovska, P Rodrigues, M Ramos, D Moreno-Dominguez, S Puch, ...",,,0,0
Signaling networks in MS: A systems-based approach to developing new pharmacological therapies,"RM Tegner, A Zamora, F Paul, J Saez-Rodriguez, P Villoslada",,,0,0
Letter to the editor: Clinical characteristics of responders to interferon beta therapy in MS,"P Villoslada, JR Oksenberg, J Rio, X Montalban",,,0,0
"2019 Stockholm, Sweden","A Gulati, F Bagnato, P Villoslada, NV de Mendizabal",,,0,0
Unequivocal linkage to multiple sclerosis of the MS-associated retrovirus in distinct European populations,"G Arru, A Dolei, M Sodestrom, G Mameli, V Astone, C Serra, H Link, ...",,,0,0
Poster 130,"GL Traber1A, T Oberwahrenbrock, I Gabilondo, R Nolan4A, ...",,,0,0
Statistical Theory and Method Abstracts–Zentralblatt Database,"J Goni, I Martincorena, G Arrondo, J Sepulcre, N Vélez, B Bejarano, ...",,,0,0
Use Of Wide-Field Retinography For Periphlebitis Detection In Patients With Multiple Sclerosis.,"R Torres-Torres, E Fraga-Pumar, P Villoslada, BF Sanchez-Dalmau",,,0,0
T3 administration ameliorates the demyelination/remyelination ratio in a non-human primate model of multiple sclerosis by correcting tissue hypothyroidism.,"G D’Intino, L Lorenzini, M Fernandez, A Taglioni, G Perretta, ...",,,0,0
Retrograde axonal and neuronal degeneration of the retina in acute optic neuritis,"I Gabilondo, E Martínez-Lapiscina, E Fraga-Pumar, S Ortiz-Perez, ...",,,0,0
Wired minds: The neural underpinning of the entrepreneurial brain,"PR Rodrigues, D Moreno-Dominguez, M Ramos, P Villoslada, ...",,,0,0
SUPPLEMENTARY ONLINE MATERIAL 2,"A Gulati, F Bagnato, P Villoslada, NV de Mendizabal, N Branch",,,0,0
Dynamics of Bystander Cytotoxic T Cells Activation in a Model of Autoimmunity,"S Chang, N Leslie, B Long, P Villoslada",,,0,0
Mapping the brain pathways of declarative verbal memory: Evidence from white matter lesions in the living human brain,"NV de Mendizabal, MA Pastor, BB Herruzo, P Villoslada",,,0,0
Study Of The Dynamics Of Axonal Degeneration In Chemotherapy-Induced Neuropathy By In Vivo Corneal Confocal Microscopy.,"R Torres-Torres, M Lopez-Moreno, M Muñoz, P Villoslada, ...",,,0,0
Color vision is strongly associated with retinal thinning in multiple sclerosis. Mult Scler,P Villoslada,,,0,0
Reproducibility of the structural connectome and other open challenges,"P Rodrigues, A Prats-Galino, D Gallardo-Pujol, P Villoslada, C Falcon, ...",,,0,0
ESCLEROSIS MÚLTI LE,"T Corona, J Flores, C Oreja-Guevara, G Lubrini, JA Virgili, P Villoslada, ...",,,0,0
